CytRx

$0.3405
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0295 (-7.97%) Today
$0.00 (0.00%) As of 5:00 PM EDT after-hours

Why Robinhood?

You can watch CytRx and buy or sell other stocks, options, ETFs, and crypto commission-free!

About CYTR

CytRx Corporation Common Stock, also called CytRx, is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. Read More The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Employees
6
Headquarters
Los Angeles, California
Founded
1985
Market Cap
11.35M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
31.16K
High Today
$0.3825
Low Today
$0.323
Open Price
$0.3825
Volume
74.54K
52 Week High
$1.27
52 Week Low
$0.255
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.